Bone Morphogenetic Protein 6 Inhibits the Immunomodulatory Property of BMMSCs via Id1 in Sjögren's Syndrome

• Autori principali: Yingying Su (Autore), Yi Gu (Autore), Ruiqing Wu (Autore), Hao Wang (Autore)
• Natura: Libro
• Pubblicazione: Hindawi Limited, 2018-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Mesenchymal stem cells (MSCs) treatment has emerged as a promising approach for treating Sjögren's syndrome (SS). Impaired immunoregulatory activities of bone marrow mesenchymal stem cells (BMMSCs) are found in both SS patients and animal models, and the underlying mechanism is poorly understo...